Good Morning GCANers. Another day were we are closer to the introduction of the long awaited OralTab to be announced as being sold. We know it will be, we just don't know the time line except 1st Quarter of 2020 as illustrated in the following Symtomax presentation. Take the time to click on the links below and read them carefully because it is very evident this is the future of GCAN as GCAN or as a subsidiary of Symtomax! Symtomax has already publicy announced they wanted to become a fully reporting company on a North American Exchange and GCAN is a fully reporting Company in the U.S. The question right now is the time line. Could be today, tomorrow or next week, no one knows but after fighting a scheduled 15 round fight and being in maybe the 14th round, NO one is going to convince me to sell any shares at all. We are so very close. The presentation alone gives us a time line so for many this is 'Almost There'!
Maybe someone can kick Aitan in the balls and suggest he update HIS shareholders and the investment community instead of us having to find out all this information from Third Parties although Third Party confirmation from a company like Symtomax and especially their Leadership team certainly supports a bright future for both. IMHO
This is the company bringing the Oraltab to market. Pay very close attention to who is the leadership team at Symtomax and their business history and successes:
https://www.symtomax.com/
Here is the website link owned by Symtomax that we are waiting to come live to sell the OralTab:
http://www.oraltabs.com/
This is Symtomax's presentation they are making for their bond offering and GCAN is described in this presentation and how the OralTab is going to play an important role in their financial future:
https://584b0793-b92b-45b5-9ba6-9836eefa77ad....3a9eb7.pdf
This is a most recent article in a European publication explaining Symtomax and it's relations with GCAN for the future:
https://www.healtheuropa.eu/symtomax-the-medi...eld/94127/
This is one of many presentations being made by financial institutions promoting the sale of Symtomax bond offering to help finance the future growth and manufacturing ability of Symtomax:
https://www.rml-advisory.ch/private-assets
Maybe someone can kick Aitan in the balls and suggest he update HIS shareholders and the investment community instead of us having to find out all this information from Third Parties although Third Party confirmation from a company like Symtomax and especially their Leadership team certainly supports a bright future for both. IMHO
This is the company bringing the Oraltab to market. Pay very close attention to who is the leadership team at Symtomax and their business history and successes:
https://www.symtomax.com/
Here is the website link owned by Symtomax that we are waiting to come live to sell the OralTab:
http://www.oraltabs.com/
This is Symtomax's presentation they are making for their bond offering and GCAN is described in this presentation and how the OralTab is going to play an important role in their financial future:
https://584b0793-b92b-45b5-9ba6-9836eefa77ad....3a9eb7.pdf
This is a most recent article in a European publication explaining Symtomax and it's relations with GCAN for the future:
https://www.healtheuropa.eu/symtomax-the-medi...eld/94127/
This is one of many presentations being made by financial institutions promoting the sale of Symtomax bond offering to help finance the future growth and manufacturing ability of Symtomax:
https://www.rml-advisory.ch/private-assets
